why choose us

First received: October 23, 2023

Clinical Trial: Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Toxic Epidermal Necrolysis

Study Type: INTERVENTIONAL


Official Title: Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis: a Single-arm, Open, Single-center Study

Brief Summary: To evaluate the efficacy and safety of methylprednisolone combined with the JAK inhibitor abxitinib in the treatment of toxic epidermal necrolysis

Read more